Dx & Vx Co., Ltd. Logo

Dx & Vx Co., Ltd.

Develops innovative diagnostics & vaccines and provides comprehensive life science contract services.

180400 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 금천구 디지털로 173, 금천구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Dx & Vx Co., Ltd. is a global bio-healthcare company focused on developing innovative diagnostics (Dx) and vaccines (Vx). The company leverages proprietary technologies, including a platform for long-term, room-temperature storage of mRNA vaccines and a universal Next-Generation Sequencing (NGS) platform. Its R&D pipeline targets infectious diseases, immuno-oncology, obesity, and eye diseases. In addition to its drug development, Dx & Vx provides a comprehensive suite of services to the life sciences industry, including contract development (CDO), manufacturing (CMO), sales (CSO), and companion diagnostics (CDx) development. The company also develops microbiome-based products and offers medical data services.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Dx & Vx Co., Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-16 00:00
Pre-Annual General Meeting Information
주주총회소집결의 (임시주주총회)
Korean 8.4 KB
2025-09-16 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.7 KB
2025-08-29 00:00
M&A Activity
합병등종료보고서(자산양수도)
Korean 15.2 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.8 MB
2025-08-14 00:00
Audit Report / Information
반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
Korean 12.1 KB
2025-08-14 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 2.4 MB

Automate Your Workflow. Get a real-time feed of all Dx & Vx Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Dx & Vx Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Mezzion Pharma Co., Ltd. Logo
Develops and out-licenses novel therapeutics like udenafil, with a focus on rare diseases.
South Korea 140410
MFC Co., Ltd. Logo
A GMP-certified CDMO/CMO developing and manufacturing APIs for the global pharma sector.
South Korea 432980
Mithra Pharmaceuticals S.A. Logo
Biotech firm developing pharma for women's health: contraception, fertility, and menopause.
Belgium MITRA
MIZUHO MEDY CO.,LTD. Logo
Develops rapid diagnostic tests & gene analyzers for clinical, research & agricultural markets.
Japan 4595
MOA Life Plus Co. Ltd. Logo
Develops immunotherapies & consumer solutions for immunity, skin rejuvenation, and pet care.
South Korea 142760
Moberg Pharma Logo
Develops & commercializes a leading topical treatment for nail fungus for European markets.
Sweden MOB
Mochida Pharmaceutical Co.,Ltd. Logo
An R&D-driven company making drugs, skincare, and medical equipment for specialized fields.
Japan 4534
Develops LNP drug delivery systems for severe diseases, offering R&D to GMP manufacturing support.
South Korea 322970
MORISHITA JINTAN CO.,LTD. Logo
Manufactures health products and provides OEM/ODM services using advanced encapsulation technology.
Japan 4524
MUROMACHI CHEMICALS INC. Logo
A diversified manufacturer of pharmaceuticals, chemical systems, health foods & functional materials.
Japan 4885

Talk to a Data Expert

Have a question? We'll get back to you promptly.